The disclosure was made through a Form 8.3 filing, which is standard for opening position disclosures under Irish takeover rules. The document did not provide information about any potential takeover offer for Mural Oncology, nor did it indicate whether BlackRock intends to increase or decrease its position. BlackRock reported no short positions in Mural Oncology securities, according to the filing. This information is based on a regulatory disclosure statement submitted to the Irish Takeover Panel. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.